Arch Iran Med. 2020;23(9): 644-646. doi: 10.34172/aim.2020.78

Letter to the Editor

Case Fatality Rate of COVID-19: Meta-Analysis Approach

Amir Almasi-Hashiani 1 ORCID, Amin Doosti-Irani 2 ORCID, Mohammad Ali Mansournia 3 * ORCID

Cited by CrossRef: 4

1- Mousavi-Hasanzadeh M, Sarmadian H, Safi F, Jamalian M, Almasi-Hashiani A. Epidemiological and Clinical Characteristics of Patients with COVID-19 in Arak, Iran. TOPHJ. 2020;13(1):712 [Crossref]
2- Hayashi K, Nishiura H. Time-dependent risk of COVID-19 death with overwhelmed health-care capacity in Japan, 2020–2022. BMC Infect Dis. 2022;22(1) [Crossref]
3- Noori M, Azizi S, Abbasi Varaki F, Nejadghaderi S, Bashash D. A systematic review and meta-analysis of immune response against first and second doses of SARS-CoV-2 vaccines in adult patients with hematological malignancies. International Immunopharmacology. 2022;110:109046 [Crossref]
4- Ye Q, Zhang T, Lu D. Potential false‐positive reasons for SARS‐CoV‐2 antibody testing and its solution. Journal of Medical Virology. 2021;93(7):4242 [Crossref]

SCImago Journal & Country Rank

About Us

A Monthly Peer-Reviewed Medical Journal Published by the Academy of Medical Sciences of the I.R. Iran; Indexed in PubMed/MEDLINE, ISI Web of Science, EMBASE, SCOPUS, CINHAL, PASCAL, CSA, SID, ISSN: Print 1029-2977, Online 1735-3947.The impact factor of Archives of Iranian Medicine according to Journal Citation Reports® (JCR®) 2016 is 1.20.